Search Results

Displaying Results 1-2 of 2 "'HCWB'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

Feb 19, 2026, 17:31 ET Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

companies, such as AbbVie (NYSE: ABBV), Q32 Bio (NASDAQ: QTTB), Legacy Healthcare, Almirall (BME: ALM), Sanofi (EPA: SAN), HCW Biologics (NASDAQ: HCWB), ALYS Pharmaceuticals, Dren Bio, Nektar Therapeutics (NASDAQ: NKTR), and others, are developing new alopecia areata treatment drugs that can be

More news about: DelveInsight Business Research, LLP

Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics

Sep 18, 2025, 09:10 ET Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics

2015 to 2 billion by 2050[2]. These macro forces position Avant Technologies, Inc. (OTCQB: AVAI), HCW Biologics Inc. (NASDAQ: HCWB), Solid Biosciences Inc. (NASDAQ: SLDB), ProMIS Neuorsciences, Inc. (NASDAQ: PMN), and uniQure N.V. (NASDAQ: QURE).

More news about: USA News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.